Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

582
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

1.1K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
1.1K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

1.1K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Overview of Skeletal Muscle01:15

Overview of Skeletal Muscle

17.1K
Skeletal muscles are composed of a bundle of muscle fibers and are attached to bones through tendons. Each skeletal muscle fiber is a single muscle cell. The sarcolemma, the plasma membrane of a skeletal muscle cell, consists of a lipid bilayer and glycocalyx that supports muscle fibers. The sarcolemma extends into the muscle cells to form tubular structures called transverse or T-tubules. Each side of the T-tubules consists of a membrane-bound structure called the sarcoplasmic reticulum,...
17.1K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Nitrous oxide abuse prevalence, mechanisms, treatments and prevention.

Current medical research and opinion·2026
Same author

Identification and Characterization of Mitragynine or 7-Hydroxymitraynine Oral Dosage Form Products That Appeal to Children.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2026
Same author

Compounded Semaglutide and Tirzepatide Products Use Unique Formulations but Efficacy and Safety Largely Unknown.

The Annals of pharmacotherapy·2026
Same author

Nonswallowed Kratom-Derived Products: Unlawful Dietary Supplements That Endanger Public Health.

Public health reports (Washington, D.C. : 1974)·2026
Same author

Transdermal "Natural GLP-1" Dietary Supplements Violate Law and Place Patients at Risk.

The Annals of pharmacotherapy·2026
Same author

Correction: Use of SGLT2 Inhibitors in Pediatric Heart Failure: A Multi-Eenter Study.

Pediatric cardiology·2025

Video Experimental Relacionado

Updated: Mar 29, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.2K

Efecto de las estatinas en la función del músculo esquelético.

Beth A Parker1, Jeffrey A Capizzi, Adam S Grimaldi

  • 1Division of Cardiology, Henry Low Heart Center, Hartford Hospital, Hartford, CT, USA.

Circulation
|November 28, 2012
PubMed
Resumen

Las dosis altas de atorvastatina no afectaron la fuerza muscular o la capacidad de ejercicio en individuos sanos. Sin embargo, las estatinas aumentaron las quejas musculares y lesiones musculares leves, lo que sugiere que se necesita más investigación.

Más Videos Relacionados

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

12.4K

Videos de Experimentos Relacionados

Last Updated: Mar 29, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.2K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

12.4K

Área de la Ciencia:

  • Cardiología Cardiología.
  • Neurología Neurología.
  • Fisiología del ejercicio Fisiología del ejercicio

Sus antecedentes:

  • Los médicos a menudo sospechan que las estatinas causan dolor muscular, pero los ensayos clínicos no lo han demostrado consistentemente.
  • El impacto de las estatinas en la función y el rendimiento del músculo esquelético requiere más investigación.

Objetivo del estudio:

  • Para evaluar los efectos de la dosis alta de atorvastatina en la función y el rendimiento del músculo esquelético en individuos sanos que no habían tomado estatinas.
  • Evaluar si la atorvastatina tiene un impacto en la fuerza muscular, la capacidad de ejercicio y los niveles de creatina quinasa.

Principales métodos:

  • El estudio STOMP involucró a 420 sujetos sanos, nunca antes tratados con estatinas, que recibieron atorvastatina 80 mg o placebo durante 6 meses.
  • Las mediciones incluyeron la creatina quinasa, la capacidad de ejercicio, la fuerza muscular y la evaluación de los síntomas antes y después del tratamiento.

Principales resultados:

  • La atorvastatina aumentó los niveles promedio de creatina quinasa (P<0.0001) pero no alteró significativamente la fuerza muscular o la capacidad de ejercicio.
  • Más sujetos en tratamiento con atorvastatina reportaron mialgia (19 vs. 10; P=0,05) en comparación con el placebo.
  • Los sujetos miálgicos en atorvastatina mostraron una disminución de la fuerza muscular en algunas variables, pero esto no fue estadísticamente significativo en comparación con el placebo.

Conclusiones:

  • Las dosis altas de atorvastatina durante 6 meses no reducen la fuerza muscular o el rendimiento del ejercicio en sujetos sanos.
  • El estudio confirma que las estatinas pueden aumentar las quejas musculares (mialgia) y causar lesiones musculares leves, evidenciadas por un aumento de la creatina quinasa.
  • Se recomienda una mayor investigación para explorar los efectos del uso prolongado de altas dosis de estatinas en la salud muscular.